全球心臟人工智慧監測和診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，心臟人工智慧監測和診斷市場規模將從 2025 年的 16.2 億美元成長至 143.2 億美元，2026 年至 2034 年的複合年成長率為 27.41%。

由於全球心血管疾病發生率不斷上升，人工智慧驅動的心臟監測和診斷全球市場正快速成長。人工智慧能夠有效率地分析大量心臟數據，進而提高診斷準確率。穿戴式裝置的廣泛應用和遠端患者監護系統的實際部署進一步推動了市場成長。醫療服務提供者正擴大利用人工智慧進行早期檢測並改善治療效果。

關鍵促進因素包括機器學習演算法的進步以及人工智慧與影像技術的融合。心臟病學領域對預測分析日益成長的需求有助於提高臨床決策的準確性。遠端醫療服務和數位健康平台的擴展也為市場發展提供了支持。醫療保健投資的增加以及監管機構對基於人工智慧的醫療解決方案的支持，進一步鞏固了市場成長前景。

展望未來，即時監測和雲端分析技術的持續創新將拓展應用範圍。新興經濟體採用數位醫療基礎設施將創造新的成長機會。人工智慧與先進成像和穿戴式技術的融合將改善預防醫學。隨著醫療系統日益重視數據驅動的診斷，心臟人工智慧解決方案有望廣泛應用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球心臟人工智慧監測與診斷市場：按產品分類

• 市場分析、洞察與預測
• 硬體
• 軟體解決方案
• 服務

第5章 全球心臟人工智慧監測與診斷市場：按類型分類

• 市場分析、洞察與預測
• 心臟診斷
• 心臟監測

第6章 全球心臟人工智慧監測與診斷市場：按應用領域分類

• 市場分析、洞察與預測
• 心律不整
• 中風
• 缺血性心臟疾病
• 狹窄
• 其他用途

第7章 全球心臟人工智慧監測與診斷市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 診斷中心
• 研究機構和學術機構

第8章 全球心臟人工智慧監測與診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • CardiAI Inc
  • Cleerly Inc
  • DiA Imaging Analysis Ltd
  • HeartVista Inc
  • IDOVEN
  • Koninklijke Philips NV
  • RSIP Vision
  • Tempus Labs Inc
  • UltraSight Ltd
  • Ultromics Limited
  • Viz.Ai Inc

The Cardiac AI Monitoring and Diagnostics Market size is expected to reach USD 14.32 Billion in 2034 from USD 1.62 Billion (2025) growing at a CAGR of 27.41% during 2026-2034.

The Global Cardiac AI Monitoring and Diagnostics Market is growing rapidly due to increasing cardiovascular disease prevalence worldwide. Artificial intelligence enhances diagnostic accuracy by analyzing large volumes of cardiac data efficiently. Rising adoption of wearable devices and remote patient monitoring systems further fuels market growth. Healthcare providers are increasingly leveraging AI to improve early detection and treatment outcomes.

Key drivers include advancements in machine learning algorithms and integration of AI with imaging technologies. Growing demand for predictive analytics in cardiology enhances clinical decision-making. Expansion of telehealth services and digital health platforms supports market development. Increased healthcare investments and regulatory support for AI-based medical solutions further strengthen growth prospects.

Looking ahead, continuous innovation in real-time monitoring and cloud-based analytics will expand applications. Emerging economies adopting digital health infrastructure will create new growth opportunities. Integration of AI with advanced imaging and wearable technology will improve preventive care. As healthcare systems focus on data-driven diagnostics, cardiac AI solutions are expected to gain widespread adoption.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Hardware
• Software solutions
• Services

By Type

• Cardiac diagnostics
• Cardiac monitoring

By Application

• Cardiac arrhythmias
• Stroke
• Ischemic heart disease
• Stenosis
• Other applications

By End-use

• Hospitals
• Specialty clinics
• Diagnostic centers
• Research and academic institute

COMPANIES PROFILED

• CardiAI Inc, Cleerly Inc, DiA Imaging Analysis Ltd, HeartVista Inc, IDOVEN, Koninklijke Philips NV, RSIP Vision, Tempus Labs Inc, UltraSight Ltd, Ultromics Limited, Vizai Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Hardware Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Software solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Cardiac diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiac monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cardiac arrhythmias Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ischemic heart disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Specialty clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Research and academic institute Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Type
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Type
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Type
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Type
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Type
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 CardiAI Inc
  • 10.2.2 Cleerly Inc
  • 10.2.3 DiA Imaging Analysis Ltd
  • 10.2.4 HeartVista Inc
  • 10.2.5 IDOVEN
  • 10.2.6 Koninklijke Philips N.V
  • 10.2.7 RSIP Vision
  • 10.2.8 Tempus Labs Inc
  • 10.2.9 UltraSight Ltd
  • 10.2.10 Ultromics Limited
  • 10.2.11 Viz.Ai Inc